[{"Assets_0_Q3_USD":54846000.0,"CommonStockSharesOutstanding_0_Q3_shares":18057000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-1453000.0,"NetIncomeLoss_1_Q3_USD":-595000.0,"NetIncomeLoss_3_Q3_USD":-3554000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":18012000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":17931000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":18012000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":17931000.0,"StockholdersEquity_0_Q3_USD":52580000.0,"Ticker":"FLGT","CIK":"1674930","name":"FULGENT GENETICS, INC.","OfficialName":"Fulgent Genetics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1793543393.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20181109"}]